Impact of Time to Castration Resistance on Survival in Metastatic Hormone Sensitive Prostate Cancer Patients in the Era of Combination Therapies

BackgroundTo evaluate the impact of time to castration resistance (TTCR) in metastatic hormone-sensitive prostate cancer (mHSPC) patients on overall survival (OS) in the era of combination therapies for mHSPC.Material and MethodsOf 213 mHSPC patients diagnosed between 01/2013-12/2020 who subsequentl...

Full description

Bibliographic Details
Main Authors: Mike Wenzel, Felix Preisser, Benedikt Hoeh, Maria Schroeder, Christoph Würnschimmel, Thomas Steuber, Hans Heinzer, Severine Banek, Marit Ahrens, Andreas Becker, Pierre I. Karakiewicz, Felix K. H. Chun, Luis A. Kluth, Philipp Mandel
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.659135/full